Literature DB >> 11355886

Effects of ceramide on aggrecanase activity in rabbit articular cartilage.

M Sabatini1, M Thomas, C Deschamps, C Lesur, G Rolland, G de Nanteuil, J Bonnet.   

Abstract

Ceramide participates in signal transduction of IL-1 and TNF, two cytokines likely involved in cartilage degradation in osteoarthritis. We previously showed that ceramide stimulates proteoglycan degradation, mRNA expression of matrix metalloproteinase (MMP)-1, -3, and -13, and pro-MMP-3 production in rabbit cartilage. Since aggrecan, the main cartilage proteoglycan, can be cleaved by metalloproteinases both of MMP and aggrecanase type, the aim of this study was to determine if ceramide stimulates aggrecanase action and, if that is the case, in which measure aggrecanase mediates the degradative effect of ceramide. To this end, antibodies were used against the C terminal aggrecan neoepitopes generated by aggrecanases (NITEGE(373)) and MMPs (DIPEN(341)). Ceramide C(2) at 10(-5) to 10(-4) M dose-dependently increased NITEGE signal, without changing that of DIPEN, in cultured explants of rabbit cartilage. The effects of 10(-4) M C(2) on NITEGE signal and proteoglycan degradation were similarly antagonized by the metalloproteinase inhibitor batimastat, with return to the basal level at 10(-6) M. These results show that, similarly to IL-1 and TNF, ceramide-induced aggrecan degradation is mainly due to aggrecanases. That no increase of MMP activity was detected, despite stimulation of MMP expression, was probably due to lack of proenzyme conversion to mature form, since addition of a MMP activator to C(2)-treated cartilage increased both DIPEN signal and proteoglycan degradation. These findings support the hypothesis that cytokine-induced ceramide could play a mediatory role in situations of increased degradation of cartilage matrix. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11355886     DOI: 10.1006/bbrc.2001.4920

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Interruption of glycosphingolipid synthesis enhances osteoarthritis development in mice.

Authors:  Naoki Seito; Tadashi Yamashita; Yukinori Tsukuda; Yuichiro Matsui; Atsushi Urita; Tomohiro Onodera; Takeomi Mizutani; Hisashi Haga; Naoki Fujitani; Yasuro Shinohara; Akio Minami; Norimasa Iwasaki
Journal:  Arthritis Rheum       Date:  2012-08

2.  Analysis of ADAMTS4 and MT4-MMP indicates that both are involved in aggrecanolysis in interleukin-1-treated bovine cartilage.

Authors:  P Patwari; G Gao; J H Lee; A J Grodzinsky; J D Sandy
Journal:  Osteoarthritis Cartilage       Date:  2005-04       Impact factor: 6.576

3.  Exogenous sphingomyelinase increases collagen and sulphated glycosaminoglycan production by primary articular chondrocytes: an in vitro study.

Authors:  Sophie J Gilbert; Emma J Blain; Pamela Jones; Victor C Duance; Deborah J Mason
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

Review 4.  Aggrecanases and cartilage matrix degradation.

Authors:  Hideaki Nagase; Masahide Kashiwagi
Journal:  Arthritis Res Ther       Date:  2003-02-14       Impact factor: 5.156

5.  Does protein kinase R mediate TNF-alpha- and ceramide-induced increases in expression and activation of matrix metalloproteinases in articular cartilage by a novel mechanism?

Authors:  Sophie J Gilbert; Victor C Duance; Deborah J Mason
Journal:  Arthritis Res Ther       Date:  2003-11-12       Impact factor: 5.156

6.  Sphingolipids in human synovial fluid--a lipidomic study.

Authors:  Marta Krystyna Kosinska; Gerhard Liebisch; Guenter Lochnit; Jochen Wilhelm; Heiko Klein; Ulrich Kaesser; Gabriele Lasczkowski; Markus Rickert; Gerd Schmitz; Juergen Steinmeyer
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

7.  Oxygen tension modulates the effects of TNFα in compressed chondrocytes.

Authors:  R K Tilwani; S Vessillier; B Pingguan-Murphy; D A Lee; D L Bader; T T Chowdhury
Journal:  Inflamm Res       Date:  2016-09-22       Impact factor: 4.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.